407-12-5Relevant academic research and scientific papers
Compounds and Their Use for Treatment of Amyloid Beta-Related Diseases
-
Page/Page column 12, (2012/05/21)
The present invention relates to novel compounds of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said compounds, processes for making said compounds, and their use as medicaments for treatment and/or prevention of Aβ-related diseases.
Allyl esters substituted by a difluoromethylene group, their process of synthesis and their use, and a process for functionalizing a double bond
-
Page 9, (2008/06/13)
This invention provides compounds of formula: in which Rf is a radical that carries a perfluoromethylene group, which group ensures bonding to the remainder of the molecule; R1 and R3, which can be the same or different, are chosen from among hydrogen and alkyl or aryl radicals; Ψ is an electroattractor group such that Ψ-O—H is an acid whose pKa (in water) is at most equal to 8, advantageously 6, and preferably 5. These compounds are useful for the synthesis of nitrogen-containing heterocyclic compounds.
Method for functionalising a double bond
-
, (2008/06/13)
The invention concerns a method for functionalizing a double bond and, more particularly, a double bond bearing a metalloid atom. Said functionalization is produced by the action of perhalogenated sulphonyl chloride on the carbon bearing sulphur in the presence of a free radical initiator, preferably by homolytic cleavage. The invention is useful in organic synthesis.
Fluorine-containing polyfunctional (meth) acrylate composition low refractivity material and reflection reducing film
-
, (2008/06/13)
PCT No. PCT/JP97/01952 Sec. 371 Date Feb. 9, 1998 Sec. 102(e) Date Feb. 9, 1998 PCT Filed Jun. 9, 1997 PCT Pub. No. WO97/47585 PCT Pub. Date Dec. 18, 1997Fluorine-containing polyfunctional (meth)acrylate represented by the formula (1), as well as a composition, a low refractivity material and a reflection reducing film in which the (meth)acrylate is utilized: wherein X stands for a fluoroalkyl group of C1-14 having 3 or more F, or a fluorocycloalkyl group of C3-14 having 4 or more F; Y1, Y2, and Y3 stand for H, an acryloyl group or a methacryloyl group, and at least two of Y1, Y2, and Y3 stand for an acryloyl group or a methacryloyl group; Z stands for H or an alkyl group of C1-3; and n and m is an integer of 0 or 1, and n+m=1.
